$0.920
-0.029 (-3.16%)Zum Schluss
Kursprognosen
In der App öffnen, um Prognosen mit längerem Horizont freizuschalten.
GDTC-Prognose durch Analyse ähnlicher Charts
Alphio's GDTC stock price prediction model matches the current CytoMed Therapeutics Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.99 (+7.67%). The 1-week path is $0.99 (+7.77%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Soll ich CytoMed Therapeutics Ltd-Aktien kaufen?
CytoMed Therapeutics Ltd (GDTC) is not a good buy right now due to its significant downward trends and poor financial metrics. The current price is $0.92, which is down 33.81% year-to-date and 54.11% over the past year. Additionally, the stock has a negative P/E ratio of -1.91 and a forward P/E of 0, indicating a lack of profitability and future earnings potential. The RSI is at 46.19, suggesting the stock is neither overbought nor oversold, but the overall trend is negative. The main risk is the 5-day change of -10.68%, indicating a recent sharp decline in value.
GDTC schloss am Friday bei $0.92, nachdem der Kurs -3.16% fallen
CytoMed Therapeutics Ltd (GDTC) last closed at $0.92, losing -3.16%. These facts feed the 1-day and 1-week GDTC price prediction above.
Prognose-Treiber
Die Prognose-Treiber von CytoMed Therapeutics Ltd (GDTC) kombinieren ähnliche Chartmuster, Saisonalität und gleitende Durchschnitte.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Ähnliche Chartmuster
Aktien, deren jüngster Kursverlauf GDTC am ähnlichsten ist, sortiert nach Ähnlichkeit.
Saisonalitätsanalyse für GDTC
Historically the probability of a positive August return for GDTC is 0.00%. January offers the highest probability of a positive month at 4.92%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.